Fig. 5

Plasma levels of IL-1β (pg/ml) in Charcot patients (n = 28), diabetes control patients (n = 20) and healthy donors (n = 20). §P=0.029 for diabetic controls versus Charcot. Differences were not significant between diabetic controls and healthy (p=0.16) or between Charcot and healthy (p = 0.29). +P=0.027 for diabetic controls versus Charcot. Differences were not significant for diabetic controls versus healthy (p=0.016) or between Charcot and healthy (p = 0.28). Charcot at inclusion was not different from Charcot at 4 months (p = 0.07) and or at 2 years (p = 0.26). Mean ± SEM